This stock was formally Epitan (EPT). There was some buzz about it a year or two ago when they were looking at cosmetic applications for their melanotan drug. They are now more into clinical applications of the renamed drug.
It looks like they are still a couple of years off finalising the trials of the drugs. The last couple of days has seen sp climb a bit. Any one have any comments about this or the stock in general?